CN112125939A - Method for preparing high-purity 5-deoxy-D-ribose - Google Patents

Method for preparing high-purity 5-deoxy-D-ribose Download PDF

Info

Publication number
CN112125939A
CN112125939A CN202010696067.9A CN202010696067A CN112125939A CN 112125939 A CN112125939 A CN 112125939A CN 202010696067 A CN202010696067 A CN 202010696067A CN 112125939 A CN112125939 A CN 112125939A
Authority
CN
China
Prior art keywords
reaction
methanol
ribose
deoxy
mixed solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010696067.9A
Other languages
Chinese (zh)
Inventor
王相承
王刚
王思宇
李江存
李建
齐秀丽
李丹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Insititute Of Nbc Defence
Original Assignee
Insititute Of Nbc Defence
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Insititute Of Nbc Defence filed Critical Insititute Of Nbc Defence
Priority to CN202010696067.9A priority Critical patent/CN112125939A/en
Publication of CN112125939A publication Critical patent/CN112125939A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/04Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Saccharide Compounds (AREA)

Abstract

The invention discloses a preparation method of high-purity 5-deoxy-D-ribose, belonging to the technical field of chemical manufacturing separation. The technical scheme of the invention comprises the following steps: acylating 2, 3-O-isopropylidene-D-furan type methyl glucoside at 120 ℃ to obtain an intermediate A after the reaction is finished; recrystallizing 1 part of the intermediate A by using 5-20 parts of mixed solvent (mass number), wherein the mixed solvent consists of isopropanol and methanol in a mass ratio of 5: 1, and recrystallizing and purifying to obtain an intermediate B; and (3) carrying out ammonolysis reaction on the intermediate B at the reaction temperature, and carrying out post-treatment after the reaction is finished to obtain the 5-deoxy-D-ribose. Compared with the prior art, the invention has the advantages that: simple synthetic route, easily obtained raw materials, mild process conditions, low cost and convenient industrial production. The content of the 5-deoxy-D-ribose prepared by the method of the invention reaches more than 99 percent, and the purity is high.

Description

Method for preparing high-purity 5-deoxy-D-ribose
Technical Field
The invention relates to a preparation method of high-purity 5-deoxy-D-ribose, belonging to the technical field of chemical manufacturing separation.
Background
Among antitumor and antiviral drugs, a large number of nucleoside compounds are clinically used, and they are based on the principle of metabolic antagonism. The disease resistance effect is generated by interfering or inhibiting the nucleic acid replication of viruses and tumor cells. Generally, biologically active nucleosides require the presence of a 5-hydroxy group to function by phosphorylation in vivo. While removal of the 5-hydroxyl group results in a series of compounds that are of interest for biochemical and physiological studies. 5-deoxy-D-ribose is an important nucleoside drug precursor, and is widely applied to antiviral and antitumor drugs, such as 5-deoxy-5-fluorouridine, 5-deoxythymidine, 5-deoxyadenosine, Capecitabine (Capecitabine) and the like.
D-ribose has hydroxyl groups at 1-, 2-, 3-, and 5-positions, and the removal of oxygen at different positions results in different biological properties, of which 2-deoxy-D-ribose and 5-deoxy-D-ribose are particularly appreciated for their biological activity.
The synthesis technology of the 5-deoxy-D-ribose has great difficulty. 5-deoxynucleosides are generally obtained by removing the-5-hydroxyl group from the corresponding nucleoside. Because the route for synthesizing the nucleoside is long and the yield is low, the yield of the target product can be reduced more seriously by carrying out deoxidation after obtaining the nucleoside. The 5-deoxyribose is successfully developed, the 5-deoxyribose and the corresponding basic group are subjected to condensation reaction to obtain the 5-deoxynucleoside in one step, the process of the 5-deoxynucleoside compound is fundamentally changed, the yield of the target product is greatly improved, and the method has important significance.
The major problem in the synthesis of 5-deoxy-D-ribose is the difficulty of the isolation method, as described in "Kiss J D, Souza R, et al Helv Chim Acta, 1982, 65 (5): 1522-: 5534 and 5540 ", the method adopts D-ribose as raw material, halogenated (brominated or iodinated) after hydroxyl protection, and separated by a column after reduction and dehalogenation; "Wangcheng, Wanggang, Qucongol. chemical world, 2008, 4: 226- "improves the synthesis method of 5-deoxy-D-ribose, uses D-ribose as raw material, forms 2, 3-O-isopropylidene-D-furan type methyl glucoside by acetone/methanol protection, after iodomethane is iodinated, catalytic hydrogenation is carried out, and hydrolysis is carried out under the condition of acidic cation resin to obtain 5-deoxy-D-ribose, but the problem of column separation of the final product is still not solved. The column separation efficiency is low, a large amount of leacheate is needed, the energy consumption is high, time and labor are wasted, and the industrial application is difficult.
The content of the 5-deoxy-D-ribose sold in the market at present is 95 to 98 percent, the price is high, and the method is greatly limited by the productivity and the separation technology. In the synthesis process of the ribose compounds, the post-treatment is difficult, the syrup is easy to be formed, and the separation and purification method is always difficult.
Disclosure of Invention
The invention aims to overcome the problems in the prior art and provide a preparation method of high-purity 5-deoxy-D-ribose. The method takes 2, 3-O-isopropylidene-D-furan type methyl glycoside (namely 1-methyl-2, 3-O-isopropylidene-5-deoxy-D-furanoside) as a starting material to prepare high-purity 5-deoxy-D-ribose through two-step reaction. The production technology of the used raw materials is mature, cheap and easily available, the process conditions are simple and mild, and the industrial production is convenient to realize. The content of the 5-deoxy-D-ribose prepared by the method reaches more than 99 percent.
In order to achieve the technical purpose, the invention adopts the following technical scheme.
A method for preparing high-purity 5-deoxy-D-ribose, which is characterized by comprising the following steps:
a) acylating 2, 3-O-isopropylidene-D-furan type methyl glucoside at 120 ℃ to obtain an intermediate A after the reaction is finished;
b)1 part of the intermediate A is recrystallized by using 5 to 20 parts (mass number) of mixed solvent, and the mixed solvent consists of isopropanol and methanol in a mass ratio of 5: 1; recrystallizing and purifying to obtain an intermediate B;
c) and (3) carrying out ammonolysis reaction on the intermediate B at the reaction temperature, and carrying out post-treatment after the reaction is finished to obtain the 5-deoxy-D-ribose.
Wherein, the acylation reaction in the step a) refers to the reaction of 2, 3-O-isopropylidene-D-furan type methyl glucoside and an acylating agent, and the acylating agent is formed by mixing glacial acetic acid and acetic anhydride in a mass ratio of 5: 5. After the reaction is finished, distilling to recover acetic acid and acetic anhydride to obtain a crude product, namely an intermediate A;
recrystallizing and purifying the crude product A in the step B) by using an isopropanol-methanol mixed solvent to obtain an intermediate B. Specifically, 1 part of the intermediate A is recrystallized by using 5 to 20 parts (mass number) of mixed solvent, the mixed solvent is composed of 5: 1 (mass ratio) of isopropanol and methanol, the intermediate A is heated to the reflux temperature by using the mixed solvent, stirred, filtered by using a G4 filter plate (the aperture is 3-4 μm), insoluble substances are filtered out, the filtrate is cooled to 5 to 10 ℃ to be crystallized and separated out for more than 12 hours, filtered and dried, and the product intermediate B is obtained.
The ammonolysis reaction in the step c) refers to the dissociation reaction of the intermediate B in ammonia-methanol. Specifically, 1 part of the intermediate B is reacted in 5 to 20 parts (by mass) of ammonia-methanol at about 25 ℃. The ammonia-methanol solution is prepared by introducing 25 parts of liquid ammonia (or ammonia gas) into 100 parts of methanol at 0 deg.C and mixing.
Further, the post-treatment of the ammonolysis reaction in the step C) means that after the ammonolysis reaction, the reaction liquid is firstly subjected to vacuum distillation at 35 ℃, 5 times of mass of methanol is added into the residue C, the mixture is cooled to 10 ℃ and filtered, and the filtrate is distilled at 35 ℃ and the vacuum degree of 0.98MPa-0.99MPa to remove the solvent, so that colorless to light yellow slurry liquid, namely 5-deoxy-D-ribose is obtained. Product characterization, [ alpha ]]D 25=+11(C4, H2O);MS(m/z):M+: 134.0662 (relative molecular mass 134.0567), and the content is 99.1-99.3%.
Compared with the prior art, the invention has the advantages that: the preparation method is simple, the raw materials are easy to obtain, the process conditions are mild, the cost is lower, and the industrial production is facilitated.
Detailed Description
The present invention will be further described with reference to the following examples.
Example 1
Adding 50ml of glacial acetic acid and 50ml of acetic anhydride into a 500ml reaction bottle, then adding 30g of 2, 3-O-isopropylidene-D-furan type methyl glucoside, heating to 120 ℃, carrying out reflux reaction for 7.5 hours to carry out acylation reaction on the 2, 3-O-isopropylidene-D-furan type methyl glucoside, and after the reaction is finished, carrying out reduced pressure distillation to remove the glacial acetic acid and the acetic anhydride to obtain a viscous oily intermediate A crude product, wherein the crude product is about 30.05 g.
And (II) adding 30.05G of the crude intermediate A into a mixed solution formed by 125G of isopropanol and 25G of methanol, heating to reflux, keeping the reflux for 45 minutes, stopping heating, slowly cooling, filtering by using a G4 filter plate (the pore diameter is 3-4 mu m) when the temperature is reduced to 25 ℃, filtering out insoluble substances, cooling the filtrate to 5-10 ℃, crystallizing and separating out for more than 12 hours, filtering, and drying to obtain 27.32G of intermediate B and white crystals with the content of 99.5%.
And step three, introducing 25 parts by mass of liquid ammonia (or ammonia gas) into 100 parts by mass of methanol at 0 ℃ to prepare ammonia-methanol. 20.00g of intermediate B was added to 100g of ammonia-methanol, and the reaction was carried out at 25 ℃ for 24 hours with stirring. After the reaction is finished, heating to 35 ℃ for vacuum distillation, adding 5 times mass number of methanol into the distillation residue C, cooling to 10 ℃, filtering, distilling the filtrate at 35 ℃ under the vacuum degree of 0.98MPa-0.99MPa to remove the solvent, and obtaining 15.23g of colorless slurry liquid, namely 5-deoxy-D-ribose. Product characterization, [ alpha ]]D 25=+11(C4,H2O);MS(m/z):M+: 134.0662 (relative molecular mass 134.0567), content 99.1%.
Example 2
Step (one) is the same as example 1
And (II) adding 30.05G of the crude intermediate A into a mixed solution formed by 500G of isopropanol and 100G of methanol, heating to reflux, keeping the reflux for 120 minutes, stopping heating, slowly cooling, filtering by using a G4 filter plate (the pore diameter is 3-4 mu m) when the temperature is reduced to 25 ℃, filtering out insoluble substances, cooling the filtrate to 5-10 ℃, crystallizing and separating out for more than 12 hours, filtering, and drying to obtain 25.65G of intermediate B and white crystals with the content of 99.8%.
And step three, introducing 25 parts by mass of liquid ammonia (or ammonia gas) into 100 parts by mass of methanol at 0 ℃ to prepare ammonia-methanol. 20.00g of intermediate B was added to 400g of ammonia-methanol, and the reaction was carried out at 25 ℃ for 24 hours with stirring. After the reaction is finished, heating to 35 ℃ for vacuum distillation, adding 5 times mass number of methanol into the residue C, cooling to 10 ℃, filtering, distilling the filtrate at 35 ℃ under the vacuum degree of 0.98MPa-0.99MPa to remove the solvent, and obtaining 14.88g of colorless slurry liquid, namely 5-deoxy-D-ribose. Product characterization, [ α ] D25 ═ 11(C4, H2O); MS (m/z): m +: 134.0662 (relative molecular mass 134.0567), content 99.3%.

Claims (1)

1. A method for preparing high-purity 5-deoxy-D-ribose, which is characterized by comprising the following steps:
a) acylating 2, 3-O-isopropylidene-D-furan type methyl glucoside at 120 ℃ to obtain an intermediate A after the reaction is finished;
b)1 part of the intermediate A is recrystallized by using 5 to 20 parts (mass number) of mixed solvent, and the mixed solvent consists of isopropanol and methanol in a mass ratio of 5: 1; recrystallizing and purifying to obtain an intermediate B;
c) and (3) carrying out ammonolysis reaction on the intermediate B at the reaction temperature, and carrying out post-treatment after the reaction is finished to obtain the 5-deoxy-D-ribose.
Wherein, the acylation reaction in the step a) refers to the reaction of 2, 3-O-isopropylidene-D-furan type methyl glucoside and an acylating agent, and the acylating agent is formed by mixing glacial acetic acid and acetic anhydride in a mass ratio of 5: 5. After the reaction is finished, distilling to recover acetic acid and acetic anhydride to obtain a crude product, namely an intermediate A;
recrystallizing and purifying the crude product A in the step B) by using an isopropanol-methanol mixed solvent to obtain an intermediate B. Specifically, 1 part of the intermediate A is recrystallized by using 5 to 20 parts (mass number) of mixed solvent, the mixed solvent is composed of 5: 1 (mass ratio) of isopropanol and methanol, the intermediate A is heated to the reflux temperature by using the mixed solvent, stirred, filtered by using a G4 filter plate (the aperture is 3-4 μm), insoluble substances are filtered out, the filtrate is cooled to 5 to 10 ℃ to be crystallized and separated out for more than 12 hours, filtered and dried, and the product intermediate B is obtained.
The ammonolysis reaction in the step c) refers to the dissociation reaction of the intermediate B in ammonia-methanol. Specifically, 1 part of the intermediate B is reacted in 5 to 20 parts (by mass) of ammonia-methanol at about 25 ℃. The ammonia-methanol solution is prepared by introducing 25 parts of liquid ammonia (or ammonia gas) into 100 parts of methanol at 0 deg.C and mixing.
Further, the post-treatment of the ammonolysis reaction in the step C) means that after the ammonolysis reaction, the reaction liquid is firstly subjected to vacuum distillation at 35 ℃, 5 times of mass of methanol is added into the residue C, the mixture is cooled to 10 ℃ and filtered, and the filtrate is distilled at 35 ℃ and the vacuum degree of 0.98MPa-0.99MPa to remove the solvent, so that colorless to light yellow slurry liquid, namely 5-deoxy-D-ribose is obtained.
CN202010696067.9A 2020-07-16 2020-07-16 Method for preparing high-purity 5-deoxy-D-ribose Pending CN112125939A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010696067.9A CN112125939A (en) 2020-07-16 2020-07-16 Method for preparing high-purity 5-deoxy-D-ribose

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010696067.9A CN112125939A (en) 2020-07-16 2020-07-16 Method for preparing high-purity 5-deoxy-D-ribose

Publications (1)

Publication Number Publication Date
CN112125939A true CN112125939A (en) 2020-12-25

Family

ID=73851124

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010696067.9A Pending CN112125939A (en) 2020-07-16 2020-07-16 Method for preparing high-purity 5-deoxy-D-ribose

Country Status (1)

Country Link
CN (1) CN112125939A (en)

Similar Documents

Publication Publication Date Title
AU2021286276B2 (en) Compositions and methods for phosphoramidite and oligonucleotide synthesis
CN112979733B (en) Anti-hepatitis B virus compound and preparation method and application thereof
CN113980024B (en) Preparation method of adefovir intermediate compound
CN108440596B (en) Novel preparation process of tenofovir alafenamide hemifumarate
CN112125939A (en) Method for preparing high-purity 5-deoxy-D-ribose
CN105524065B (en) A kind of Ganciclovir preparation method
WO2021092919A1 (en) Nicotinamide mononucleotide intermediate and method for synthesizing nicotinamide mononucleotide
CN114380877B (en) Preparation method of 2' -deoxy-2 ' -beta-fluoro-4 ' -azidocytidine
CN101717420B (en) Novel method for synthesizing uridine
CN111499675B (en) Synthetic method of fludarabine phosphate
WO2007099388A1 (en) An improved process for the manufacture of topiramate
CN110041161A (en) Two iodo -3- methyl but-1-ene compound of (3R) -2,4- and its preparation method and application
CN111961056A (en) Method for simultaneously synthesizing hypoxanthine and tetraacetyl ribose by utilizing inosine
CN107602648B (en) Preparation method of 5' -adenylic acid
CN108203396B (en) Synthesis of enkephalinase inhibitor
CN108373491B (en) Preparation method of nelarabine
CN111808157B (en) Preparation method of adenosine bulk drug
CN113173957B (en) Synthesis method and application of vidarabine monophosphate
CN111606929B (en) Preparation method of Degatinib
CN114057813B (en) Method for synthesizing citicoline sodium
CN117362370B (en) Nucleoside phosphoramidite monomer and preparation method and application thereof
CN114380694B (en) Synthesis method for preparing indobufen intermediate by continuous flow
CN111004300B (en) Method for preparing Sofosbuvir
CN113880903B (en) Preparation method of monabivalir
CN111087380B (en) Preparation method of ticagrelor intermediate

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination